Theragenics Corporation · Buford, GA United States (NYSE: TGX)
| 5203 Bristol Industrial Way | Phone: 770-271-0233 |
| Buford, GA | Fax: 770-831-5294 |
| 30518 | |
| United States | 
Map This Company |
Theragenics Corporation Rankings
More Companies in These Related Industries: Pharmaceutical Preparation Mfg, Personal Safety Equipment MfgCompany Description
Mighty oaks and powerful cancer treatments both can originate from tiny seeds. Theragenics' seeds, sold under the names TheraSeed and I-Seed, are tiny rice-sized radioactive implants used to fight prostate cancer. The devices (known more generally as brachytherapy seeds) are a common treatment for early-stage prostate cancer; they release radiation within the tumor that kills cancerous cells with minimal damage to surrounding healthy tissue. Theragenics sells the devices directly to hospitals and through distribution agreements throughout the US and in Europe. In addition to its brachytherapy business, Theragenics' surgical products unit makes vascular and wound care products, including sutures and guidewires.
Theragenics Corporation Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NYSE: TGX Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 500 |
Executives
24 executives listed for Theragenics Corporation's Buford, GA location.
| Chairman, President, and CEO | M. Christine Jacobs | |
|---|---|---|
| CFO and Treasurer | Francis Tarallo | |
| Secretary and EVP Strategy and Business Development | Bruce Smith |